June 2, 2011

Schiff Nutrition on Tuesday announced its $40 million acquisition from Ganeden Biotech of the worldwide exclusive rights to use the probiotic technology GanedenBC30 in the over-the-counter and dietary supplement space, along with the brands Sustenex and Digestive Advantage, under which GanedenBC30 currently is sold.

May 31, 2011

The Food and Drug Administration has approved a treatment for diarrhea caused by a bacterial infection.

May 31, 2011

Researchers at Children's Hospital Boston have discovered the reason why influenza may induce asthma attacks among children.

May 26, 2011

Eli Lilly is temporarily barred from using the same sales team to market two diabetes drugs, under a court order issued Thursday.

May 26, 2011

A milk formula for babies made by Gerber Products can reduce the risk of atopic dermatitis, and Gerber has the Food and Drug Administration’s permission to say so.

May 26, 2011

A recent Quest Diagnostics "Health Trends Report" released Wednesday raised the possibility that men have a higher risk for allergies than women or that men, as a function of their gender, require different reporting standards when evaluated for allergies with increasingly used blood tests.

May 25, 2011

Researchers from the University of Texas Health Science Center at Houston found that patients with diabetes are at higher risk of contracting tuberculosis, a deadly bacterial disease, than nondiabetics.

May 24, 2011

Several states are cutting funding to programs that provide HIV medications to people who can’t afford them in an effort to reduce spending, according to a published report.

May 24, 2011

Ragweed and mold are driving increased allergies across America, Quest Diagnostics reported Monday.

May 24, 2011

A drug made by Daiichi-Sankyo was safe and effective in maintaining reductions in blood pressure in older patients, according to a new study presented at the American Society of Hypertension’s 26th annual meeting in New York.

May 23, 2011

The Food and Drug Administration has approved a treatment for hepatitis C made by Vertex Pharmaceuticals, the agency said Monday.

May 23, 2011

The $290 billion that poor medication adherence costs the U.S. economy every year cuts across every imaginable disease state, but one in which it can be particularly problematic is mental health.


May 23, 2011


It’s not often a niche brand manufacturer attempts to resuscitate what has been for years a commoditized category. But that’s exactly what Meda Consumer Healthcare will be attempting to do with iron — establish a good/better/best proposition to a supplemented category best defined as mediocre.

May 23, 2011

Chapped and cracked lips have long been a side effect associated with the common cold, especially for those congested sufferers who have to breathe strictly through their mouths.

May 20, 2011

The Council for Responsible Nutrition on Thursday issued a statement regarding the growing controversy surrounding Lazy Cakes — a brownie containing melatonin, an ingredient that helps establish more normal sleeping patterns — that has been cited in a New York Times article as having “flagrantly mimic[ked] the soothing effects of hash brownies.”

May 20, 2011

The Food and Drug Administration has approved a new antiretroviral treatment for HIV made by Johnson & Johnson, the agency said Friday.

May 20, 2011

A Food and Drug Administration advisory committee has voted to recommend that the FDA retain approval of an Abbott drug for high cholesterol in combination with a statin.

May 19, 2011

For the second consecutive year, the Exergen temporal artery thermometer outsold all other brands at retailers nationwide, Exergen announced Thursday.

May 18, 2011

Regional supermarket chain Fresh & Easy said that it is augmenting its gluten-free products range and will highlight the new offerings in stores through additional displays.

May 18, 2011

An insect repellent brand has revamped its product line.

May 17, 2011

Inventure Foods is expanding its licensed line of Jamba Juice at-home offerings with a fourth flavor.

May 17, 2011

A court in France has ordered generic drug maker Mylan to pay French drug maker Ipsen $24 million for allegedly misleading marketing of a drug, according to published reports.

May 16, 2011

The Food and Drug Administration has approved a new treatment for chronic hepatitis C, the agency said Friday.

May 13, 2011

According to a report in the May issue of Cell Metabolism, while drugs known as thiazolidinediones, or TZDs, are widely used in diabetes treatment, they have effects on the kidneys that lead to fluid retention as the volume of plasma in the bloodstream expands.